Anti-Human ITGAL & CD11a & CD18 Recombinant Antibody

Name: Anti-Human ITGAL & CD11a & CD18 Recombinant Antibody
Brand: KMD Bioscience
SKU: YR1202

YR1202

科研级 Rovelizumab ( 罗维珠单抗 ), Anti-ITGAL & CD11a & CD18 Recombinant Antibody, Research Grade Rovelizumab

DATASHEET MSDS

Product Description

Alias	科研级 Rovelizumab ( 罗维珠单抗 ), Anti-ITGAL & CD11a & CD18 Recombinant Antibody, Research Grade Rovelizumab
Catalog Number	YR1202
Molecular Name	Rovelizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG4
Formulation	PBS, pH7.5
Background	Rovelizumab, also known as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosuppressive drug. Rovelizumab was developed by Icos to treat patients suffering from haemorrhagic shock. The drug is a monoclonal antibody that suppresses white blood cells which become overly active during shock.
CAS Number	339086-79-2
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	ITGAL & CD11a & CD18[Homo sapiens]

Login